FIVE CRITICAL INFLECTION POINTS IN ALZHEIMER’S: GUIDEPOSTS FOR SMARTER DRUG DEVELOPMENT
Bart De Strooper (Belgium)
INNATE IMMUNITY AS TREATMENT TARGET IN ALZHEIMER’S DISEASE
Michael Heneka (Luxenburg)
UNDERSTANDING NEURODEGENERATIVE DISEASES TODAY: LESSONS FROM CLINICOPATHOLOGICAL CORRELATIONS AND THE ONGOING ROLE OF NEUROPATHOLOGY IN THE BIOMARKER AGE
Lea Grinberg (USA)
KEY SLEEP ISSUES PERTINENT TO THE DEVELOPMENT AND PROGRESSION OF NEURODEGENERATION IN LEWY BODY DISEASE AND RELATED DISORDERS
Bradley Boeve (USA)